Ligand Pharmaceuticals Inc (LGND)
113.45
-2.00
(-1.73%)
USD |
NASDAQ |
Nov 15, 11:24
Ligand Pharmaceuticals Gross Profit (Annual): 120.80M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 120.80M |
| December 31, 2022 | 143.42M |
| December 31, 2021 | 179.37M |
| December 31, 2020 | 133.14M |
| December 31, 2019 | 108.94M |
| December 31, 2018 | 245.12M |
| December 31, 2017 | 135.74M |
| December 31, 2016 | 103.40M |
| December 31, 2015 | 66.11M |
| December 31, 2014 | 55.40M |
| December 31, 2013 | 43.24M |
| December 31, 2012 | 27.79M |
| December 31, 2011 | 25.13M |
| December 31, 2010 | 23.54M |
| December 31, 2009 | 38.94M |
| Date | Value |
|---|---|
| December 31, 2008 | 27.32M |
| December 31, 2007 | 12.89M |
| December 31, 2006 | |
| December 31, 2005 | |
| December 31, 2004 | 93.85M |
| December 31, 2003 | 54.56M |
| December 31, 2002 | 57.03M |
| December 31, 2001 | 62.39M |
| December 31, 2000 | 39.52M |
| December 31, 1999 | 30.41M |
| December 31, 1998 | 22.20M |
| December 31, 1997 | 61.50M |
| December 31, 1996 | 46.20M |
| December 31, 1995 | 28.20M |
| December 31, 1994 | -11.40M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
108.94M
Minimum
2019
179.37M
Maximum
2021
137.13M
Average
133.14M
Median
2020
Gross Profit (Annual) Benchmarks
| Regeneron Pharmaceuticals Inc | 11.30B |
| Agios Pharmaceuticals Inc | 23.94M |
| ADMA Biologics Inc | 88.94M |
| Pieris Pharmaceuticals Inc | -- |
| AnaptysBio Inc | -- |